Stopping Ozempic: what actually happens when you quit semaglutide

What did @beautybyjorge actually say?

Pretty much exactly what the research predicts. The creator says "I think I'm gaining some weight" after stopping Ozempic, then adds "it's not that bad." That's it. No dramatic claims, no miracle cure narrative, no dangerous advice. Just a personal observation about what happens when you stop a GLP-1 medication. Credit where it's due: this is one of the more honest GLP-1 posts circulating on TikTok right now.

The caption, translated from Spanish, says they stopped using Ozempic and are "going up" (gaining weight), with laughing emojis. The tone is self-aware, not alarmist. But 22,900 viewers are watching this, and the implied takeaway, that post-GLP-1 weight regain is somehow mild or no big deal, deserves a closer look at what the actual data says.

Does the science back this up?

Yes, the basic fact checks out. Weight regain after stopping semaglutide is well-documented and consistent. The question is how much, and how fast.

The STEP 1 trial extension (Wilding et al., 2022, Diabetes, Obesity and Metabolism) followed participants for one year after stopping semaglutide 2.4 mg. On average, they regained two-thirds of the weight they had lost within 12 months. Cardiovascular risk markers also worsened back toward baseline. This wasn't a fringe result. It aligned with what researchers had already seen with liraglutide discontinuation in earlier trials.

A 2023 analysis by Rubino et al. in Obesity confirmed that GLP-1 receptor agonists suppress appetite partly through central nervous system pathways that return to baseline signaling once the drug is cleared. The body doesn't "learn" a new weight set point from the drug. It resumes the hormonal environment that existed before treatment.

What did they get wrong (or right)?

They got the direction right: stopping Ozempic causes weight to go up. But "it's not that bad" is where this gets complicated, and potentially misleading for viewers in different situations.

For someone who lost 10 pounds on semaglutide and has now regained two or three pounds, sure, that might genuinely feel manageable. But for someone who lost 40 or 50 pounds and stops the medication, the Wilding 2022 data suggests they could regain 25 to 35 pounds within a year. That's not a small thing metabolically or psychologically.

The creator isn't wrong about their own experience. The problem is that personal anecdote framed as reassurance can quietly communicate to viewers that discontinuation is low-stakes. For people managing type 2 diabetes, cardiovascular disease, or severe obesity, it often isn't. The SURMOUNT-4 trial (Aronne et al., 2024, JAMA) showed that continued tirzepatide use after an initial loss phase produced significantly better weight maintenance than placebo, reinforcing that these medications often need to be ongoing, not temporary.

What should you actually know?

GLP-1 receptor agonists like semaglutide work while you take them. That's not a flaw in the drug. It's just how the mechanism works, and stopping without a plan is where things go sideways for a lot of patients.

Here's what the evidence actually supports:

• Most people regain a significant portion of lost weight within 6-12 months of stopping (Wilding et al., 2022).
• The regain isn't because patients "failed." It reflects the drug's role in suppressing hunger hormones, including ghrelin, and slowing gastric emptying. Remove the drug, those signals return.
• Some patients do maintain partial weight loss after stopping, particularly those who made durable changes to eating patterns during treatment. But this is not the majority outcome in clinical trials.
• If you're stopping because of cost, side effects, or access issues, talking to a clinician before stopping matters. There may be dose-adjustment options or transition strategies worth knowing about.

The creator's lightness about this is understandable, and their experience may genuinely be mild so far. But the framing should not be the default assumption for anyone else making this decision.